| Issue Date | Title | Author(s) |
| 2022-09-23 | Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival | Xie, T; Dickson, K-A; Yee, C; Ma, Y; Ford, CE; Bowden, NA; Marsh, DJ |
| 2023-10-12 | PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics. | Travis, G; McGowan, EM; Simpson, AM; Marsh, DJ; Nassif, NT |
| 2020-06-24 | The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe. | Drápela, S; Khirsariya, P; van Weerden, WM; Fedr, R; Suchánková, T; Búzová, D; Červený, J; Hampl, A; Puhr, M; Watson, WR; Culig, Z; Krejčí, L; Paruch, K; Souček, K |
| 2022-10-01 | The silent malignant mesothelioma epidemic: a call to action | van Zandwijk, N; Rasko, JEJ; George, AM; Frank, AL; Reid, G |
| 2018-11-01 | Mouse Models to Investigate the Genetic Mechanism Underlying the Development of Non-Small Cell Lung Cancer | Chimankar, V; Harrison, C; Rahman, A; Pickles, S; Sahu, P; Watkins, N; Hansbro, P |
| 2021-06-30 | The anti-tumor effect of Curcuma phaeocaulis Cyclepeptide in human hepatoma HepG2 cells | Chen, H; Li, Y; Wu, Y; Li, Y; McGowan, E; Lin, Y |
| 2019-11-01 | Using Experimental Mouse Models to Understand the Pathogenesis of Lung Adenocarcinoma | Chimankar, V; Pickles, S; Donovan, C; Sahu, P; Rahman, A; Gomez, H; Malyla, V; Bielefeldt-Ohmann, H; Wark, P; Watkins, N; Hansbro, PM |
| 2021-07-14 | Tetranucleotide and Low Microsatellite Instability Are Inversely Associated with the CpG Island Methylator Phenotype in Colorectal Cancer | Meessen, S; Currey, N; Jahan, Z; Parker, HW; Jenkins, MA; Buchanan, DD; Hopper, JL; Segelov, E; Dahlstrom, JE; Kohonen-Corish, MRJ |
| 2022-02-01 | The aryl-ureido fatty acid CTU activates endoplasmic reticulum stress and PERK/NOXA-mediated apoptosis in tumor cells by a dual mitochondrial-targeting mechanism. | Choucair, H; Rahman, MK; Umashankar, B; Al-Zubaidi, Y; Bourget, K; Chen, Y; Dunstan, C; Rawling, T; Murray, M |
| 2022-06-09 | MCC Gene Silencing Is a CpG Island Methylator Phenotype-Associated Factor That Predisposes Colon Cancer Cells to Irinotecan and Olaparib. | Jahan, Z; Benthani, FA; Currey, N; Parker, HW; Dahlstrom, JE; Caldon, CE; Kohonen-Corish, MRJ |
